Pharmaceutical Industry Information Portal


All posts by tag


BIOCAD has registered an original drug for the treatment of rheumatoid arthritis

The Ministry of Health of the Russian Federation has approved the original drug Levilimab (Russian trade name Ilsira) for the treatment of rheumatoid arthritis...

BIOCAD has presented the results of efficacy evaluation of the Russian immuno-oncology product prolgolimab for the treatment of melanoma

In the evening of June 21, 2021, leading Russian and international cancer experts presented the results of a three-year efficacy study of the Russian...

BIOCAD has received approval from the Chinese authorities to conduct clinical trials of prololimab for the treatment of cervical cancer and NSCLC

SPH BIOCAD, a joint venture with Shanghai Pharmaceuticals Holding, which is registered in Hong Kong and has a representative office in Shanghai, has received...

Expert Articles